Humana Inc. (NYSE:HUM) Receives $315.33 Consensus Price Target from Brokerages

Shares of Humana Inc. (NYSE:HUMGet Free Report) have earned a consensus recommendation of “Hold” from the twenty-five analysts that are presently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, eighteen have assigned a hold rating and six have given a buy rating to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $315.33.

A number of research analysts have recently commented on HUM shares. Sanford C. Bernstein raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $308.00 target price on the stock in a research report on Tuesday, October 8th. Stephens reiterated an “equal weight” rating and issued a $250.00 price objective on shares of Humana in a report on Wednesday, October 9th. Oppenheimer lowered their target price on Humana from $400.00 to $280.00 and set an “outperform” rating for the company in a research note on Thursday, October 3rd. Leerink Partners cut Humana from an “outperform” rating to a “market perform” rating and cut their price target for the stock from $400.00 to $250.00 in a research note on Wednesday, October 2nd. Finally, KeyCorp started coverage on Humana in a research note on Friday, October 11th. They set a “sector weight” rating for the company.

Get Our Latest Stock Report on Humana

Humana Stock Performance

Shares of HUM stock opened at $258.41 on Tuesday. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.70. The company has a market cap of $31.14 billion, a PE ratio of 16.09, a P/E/G ratio of 1.91 and a beta of 0.50. The company’s fifty day simple moving average is $310.28 and its 200-day simple moving average is $337.43. Humana has a 52 week low of $213.31 and a 52 week high of $527.18.

Humana (NYSE:HUMGet Free Report) last released its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, beating the consensus estimate of $5.89 by $1.07. Humana had a return on equity of 16.12% and a net margin of 1.53%. The company had revenue of $29.54 billion for the quarter, compared to analyst estimates of $28.52 billion. During the same period last year, the company posted $8.94 earnings per share. The firm’s revenue was up 10.4% compared to the same quarter last year. As a group, equities research analysts anticipate that Humana will post 16.06 EPS for the current year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.37%. Humana’s payout ratio is 22.04%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Pzena Investment Management LLC raised its holdings in shares of Humana by 538.7% during the second quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider’s stock valued at $866,250,000 after buying an additional 1,955,375 shares during the last quarter. Davis Selected Advisers boosted its position in Humana by 16.1% during the 2nd quarter. Davis Selected Advisers now owns 2,311,362 shares of the insurance provider’s stock worth $863,640,000 after acquiring an additional 321,233 shares during the period. Marshall Wace LLP grew its stake in shares of Humana by 118.9% in the second quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider’s stock worth $532,564,000 after purchasing an additional 774,085 shares in the last quarter. Legal & General Group Plc increased its holdings in shares of Humana by 2.1% during the second quarter. Legal & General Group Plc now owns 1,183,985 shares of the insurance provider’s stock valued at $442,396,000 after purchasing an additional 24,842 shares during the period. Finally, Ontario Teachers Pension Plan Board raised its stake in shares of Humana by 11,647.2% during the first quarter. Ontario Teachers Pension Plan Board now owns 1,059,478 shares of the insurance provider’s stock valued at $367,342,000 after purchasing an additional 1,050,459 shares in the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

About Humana

(Get Free Report

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

See Also

Analyst Recommendations for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.